Tenth Annual Dean’s Cup Strongest Person Competition

Tenth Annual Dean’s Cup Strongest Person CompetitionIcahn School of Medicine at Mount Sinai students and staff showed off their biceps along with Dennis S. Charney, MDAnne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, during the Tenth Annual Dean’s Cup Strongest Person Competition on Monday, April 11, in the Aron Hall Gym. This contest included deadlift, bench press, squat, pull-ups, and push-ups. The Dean’s Cup is a week of fun and competition with games for all medical students, including a 3v3 basketball tournament, 5K run, table tennis, pool, soccer, and Ultimate Frisbee. Winners received Icahn School of Medicine sweatshirts, sweatpants, and other prizes.

Medical Students Host First Annual Ethics Conference

From left: Nada Gligorov, PhD, Associate Professor, Bioethics Program; Vanessa Northington Gamble, MD, PhD; and Paul J. Cummins, PhD, Education Program Manager, Medical Education, Bioethics Program.

The Icahn School of Medicine at Mount Sinai’s Bioethics Program hosted its First Annual Medical Student Ethics Conference, a forum designed to provide medical students across the country with an opportunity to discuss and resolve the ethical challenges they may encounter during physician training. A call for abstracts was issued to medical schools in the region and to several academic medicine and medical ethics organizations. Eight students from six medical schools gave poster presentations that examined such topics as “Anatomy and Cadavers as First Patients,” and “Anticipating Obligations as Future Physicians.” Keynote Speakers Vanessa Northington Gamble, MD, PhD, University Professor of Medical Humanities, George Washington University, and Robert Klitzman, MD, Professor of Clinical Psychiatry and Director of the Masters of Bioethics Program, Columbia University Medical Center, discussed, respectively, personal and historical reflections on racism, medicine, and bioethics; and the role reversal experienced when physicians become patients. The conference, funded by The Arnold P. Gold Foundation, took place on Saturday, March 19, and drew 65 participants.

Mount Sinai Vascular Surgeons Among First in Nation To Treat Complex Aortic Aneurysm With New Device

Dr Rami Tadros, Michael Marin- head of surgery, James McKinsey 98 W, 15th Fl

From left: Rami O. Tadros, MD, FACS; James F. McKinsey, MD, FACS; and Michael L. Marin, MD, FACS, are using a new-generation implantable device to treat complex thoracoabdominal aortic aneurysms.

Physicians at The Mount Sinai Hospital were among the first in the nation to implant an investigational device, a fabric and metal mesh tube known as a stent graft, as part of a clinical trial to treat aneurysms located in the thoracic/abdominal area of the aorta. Mount Sinai is one of only six institutions in the nation granted approval by the U.S. Food and Drug Administration to test the safety and initial feasibility of the device in patients.

The stent graft is used to strengthen the inner lining of the aorta—the main artery that carries blood from the heart to organs—in patients where the aortic walls have weakened and caused a balloon-type bulge known as an aneurysm to grow. Once implanted, the device serves to direct blood flow away from the aneurysm, causing it to shrink in size. If not repaired, the aneurysm can rupture and result in life-threatening internal bleeding. Read more

Enhancing Employee Health at Mount Sinai

Enhancing Employee Health at Mount Sinai

Dietitian Maria Elena Rodriguez, RD, CDE, center, helped Mount Sinai employees Angela Mazzone, left, and Valerie Ruffin achieve a healthier lifestyle.

Valerie Ruffin, an Executive Assistant in the Department of Information Technology, thought that drinking homemade fruit juices was a good way to improve her health and lose weight—until she had a physical exam in 2015. “I was in shock when I was told I had diabetes,” she recalls. “My blood work showed extremely high sugar levels, the result of all the fruit juice I was drinking daily.”

Colleague Angela Mazzone, Project Manager III, Department of Information Technology, was similarly surprised when her physical exam uncovered glucose levels consistent with pre-diabetes. She always thought of herself as a healthy eater, and athletic, but the diagnosis forced her to re-examine that perception. She was now a working mom and, in reality, she was devoting less time to exercising and preparing nutritious meals. Read more

Morningside Clinic Moves to a Newly Renovated Location

Morningside Clinic Moves to a Newly Renovated LocationThe Institute for Advanced Medicine has relocated the Spencer Cox Morningside Clinic to renovated space at 440 West 114th Street and renamed it the Morningside Clinic. The new site provides patients with a more convenient and comfortable setting that includes a spacious waiting room with a television, and a pediatric waiting area. The Morningside Clinic continues to provide patients with HIV/AIDS treatment and other services, including dental, integrative medicine, and behavioral health care. The attendees at a recent ribbon-cutting ceremony (see photo) included, from left: Vani P. Gandhi, MD, Interim Medical Director, Morningside Clinic, and Assistant Clinical Professor, Medicine (Infectious Diseases), Mount Sinai St. Luke’s; Michael P. Mullen, MD, Director, and Matt Baney, Senior Director, Institute for Advanced Medicine; and Judith A. Aberg, MD, Dr. George Baehr Professor of Clinical Medicine, and Division Chief, Infectious Diseases.

25 Years and Counting

Nada Gligorov, PhD of the Bioethics Program at ISMMS responds to a research presentation.

Nada Gligorov, PhD of the Bioethics Program at ISMMS responds to a research presentation.

The Oxford-Mount Sinai Consortium on Bioethics convened April 11–13, 2016 at the Icahn School of Medicine at Mount Sinai (ISMMS) for an exchange of research  on ethical issues in medicine and biomedical science. Celebrating its 25th anniversary, the Consortium—co-founded by Rosamond Rhodes, PhD; Stefan Baumrin, PhD, JD; and Daniel Moros, MD—is an interdisciplinary collaboration which focuses on faculty development. The annual meeting encourages its members to devote a portion of their research to bioethical topics and share their findings. Read more

Student Leads New York Forum on Dismantling Racism in Health Care

Neil Calman, MD, and Kamini Doobay

Neil Calman, MD, and Kamini Doobay

Kamini Doobay, a fourth-year medical student at the Icahn School of Medicine at Mount Sinai, played a key role in organizing a recent forum in New York City that featured renowned medical, public health, and academic leaders who convened to examine racial inequities that contribute to poorer health outcomes in communities of color.

The program, “Dismantling Racism in the NYC Health System: The Time is Now,” took place Saturday, March 12, at the CUNY Graduate Center and drew 200 participants. Ms. Doobay worked with Mount Sinai’s Department of Medical Education, the New York City Department of Health and Mental Hygiene, the CUNY Graduate School of Public Health and Health Policy, and other entities to develop the day-long activities. Read more

Meet a Winner: Kelly Hyles

Kelly Hyles“To be a winner, you must plan to win, prepare to win, and expect to win.” —Zig Ziglar

Kelly Hyles has taken the steps to become a winner and in fact, is winning already: the young woman, who has recently been accepted to 21 colleges, including all 8 Ivy League universities, is on a determined path to becoming a neurologist and the first college graduate in her family. Read more

Nutrition and Non-Alcoholic Fatty Liver Disease

ilana kersch headshot

Guest post by Ilana Kersch, MS RD CDN, Senior Dietitian at the Mount Sinai Hospital.  Ilana works as part of the inpatient liver transplant team in conjunction with the Recanati Miller Transplant Institute, and provides nutrition care for patients pre- and post-hepatobiliary surgery.

In recent decades, non-alcoholic fatty liver disease (NAFLD) has become an important cause of liver disease in the US due to its association with rising prevalence of obesity and type 2 diabetes.  It is estimated that approximately 30% of the US population now has some degree of non-alcoholic fatty liver, and ~2- 5% of the population have fatty liver which has progressed to non-alcoholic steatohepatitis (NASH).  If untreated, NAFLD and NASH can progress to liver cirrhosis and malignancy, and is quickly becoming a major indication for listing for liver transplant. Read more